Search...
GUANGJI PHARMA: Net loss of 21.7836 million yuan in the third quarter
On October 26th, GUANGJI PHARMA announced that in the third quarter of 2025, it achieved operating revenue of 145 million yuan, a year-on-year decrease of 12.57%; the net loss attributable to shareholders of the listed company was 21.7836 million yuan; basic earnings per share were -0.0628 yuan
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments